Listar por tema "surgery"

Ordenar por:Orden:Resultados:

  • Clonidine in patients undergoing noncardiac surgery 
    Devereaux, P.J.; Sessler, D.I.; Leslie, K.; Kurz, A.; Mrkobrada, M.; Alonso-Coello, P.; Villar, J.C.; Sigamani, A.; Biccard, B.M.; Meyhoff, C.S.; Parlow, J.L.; Guyatt, G.; Robinson, A.; Garg, A.X.; Rodseth, R.N.; Botto, F.; Lurati Buse, G.; Xavier, D.; Chan, M.T.V.; Tiboni, M.; Cook, D.; Kumar, P.A.; Forget, P.; Málaga Rodríguez, Germán Javier; Fleischmann, E.; Amir, M.; Eikelboom, J.; Mizera, R.; Torres, D.; Wang, C.Y.; VanHelder, T.; Paniagua, P.; Berwanger, O.; Srinathan, S.; Graham, M.; Pasin, L.; Le Manach, Y.; Gao, P.; Pogue, J.; Whitlock, R.; Lamy, A.; Kearon, C.; Chow, C.; Pettit, S.; Chrolavicius, S.; Yusuf, S. (Massachusetts Medical Society, 2014)
    BACKGROUND: Marked activation of the sympathetic nervous system occurs during and after non-cardiac surgery. Low-dose clonidine, which blunts central sympathetic outflow, may prevent perioperative myocardial infarction and ...
  • Management of Long Bones Metastatic Disease: Concepts That We All Know but Not Always Remember 
    Gonzalez, Marcos R.; Bryce-Alberti, Mayte; Pretell-Mazzini, Juan (Dove Medical Press, 2022)
    Bones are the third most common site of metastatic disease. Treatment is rarely curative; rather, it seeks to control disease progression and palliate symptoms. Imaging evaluation of a patient with symptoms of metastatic ...

Buscar en el Repositorio

Listar

Panel de Control